Artikel dengan mandat akses publik - Quynh-Thu LePelajari lebih lanjut
Tidak tersedia di mana pun: 12
The changing therapeutic landscape of head and neck cancer
JD Cramer, B Burtness, QT Le, RL Ferris
Nature reviews Clinical oncology 16 (11), 669-683, 2019
Mandat: US National Institutes of Health
Imaging the unfolded protein response in primary tumors reveals microenvironments with metabolic variations that predict tumor growth
MT Spiotto, A Banh, I Papandreou, H Cao, MG Galvez, GC Gurtner, ...
Cancer research 70 (1), 78-88, 2010
Mandat: US National Institutes of Health
Clinical utility of Epstein-Barr virus DNA testing in the treatment of nasopharyngeal carcinoma patients
KY Kim, QT Le, SS Yom, RHW Ng, KCA Chan, SV Bratman, JJ Welch, ...
International Journal of Radiation Oncology* Biology* Physics 98 (5), 996-1001, 2017
Mandat: US National Institutes of Health
Molecular profiling to optimize treatment in non-small cell lung cancer: a review of potential molecular targets for radiation therapy by the translational research program of …
NL Ausborn, QT Le, JD Bradley, H Choy, AP Dicker, D Saha, J Simko, ...
International Journal of Radiation Oncology* Biology* Physics 83 (4), e453-e464, 2012
Mandat: US National Institutes of Health
Association of high Gli1 expression with poor survival in head and neck cancer patients treated with radiation therapy (RTOG 9003).
CH Chung, J Dignam, ME Hammond, AM Magliocco, R Jordan, A Trotti, ...
Journal of Clinical Oncology 28 (15_suppl), 5552-5552, 2010
Mandat: US National Institutes of Health
Randomized phase III trial of postoperative radiotherapy with or without cetuximab for intermediate-risk squamous cell carcinoma of the head and neck (SCCHN): NRG/RTOG 0920
M Machtay, P Torres-Saavedra, WL Thorstad, PF Nguyen-Tan, LL Siu, ...
International Journal of Radiation Oncology* Biology* Physics 117 (4), e1, 2023
Mandat: US National Institutes of Health
Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma
BJ Holmes, R von Eyben, LD Attardi, CS Kong, QT Le, CAO Nathan
Head & Neck 42 (11), 3188-3196, 2020
Mandat: US National Institutes of Health
Increased galectin-1 expression in thymic epithelial tumors
JW Riess, CS Kong, RB West, SK Padda, JW Neal, HA Wakelee, QT Le
Clinical Lung Cancer 20 (3), e356-e361, 2019
Mandat: US National Institutes of Health
In Regard to Bossi et al
C Fakhry, PF Nguyen-Tân, L Lambert, DI Rosenthal, RS Weber, ...
International Journal of Radiation Oncology, Biology, Physics 102 (3), 669-670, 2018
Mandat: US National Institutes of Health
Hypoxia imaging for image-guided radiotherapy
QT Le, BW Loo, N Lee
Molecular Imaging for Integrated Medical Therapy and Drug Development, 7-18, 2010
Mandat: US National Institutes of Health
History of the Cooperative Group system (National Clinical Trials Network)
J Rosenberg, QT Le, M Machtay
Translational Radiation Oncology, 543-549, 2023
Mandat: US National Institutes of Health
Reflections on the 2021 Accreditation Council for Graduate Medical Education and American Board of Radiology Family and Medical Leave of Absence Policies: An Opportunity to …
CC Baniel, D Klebaner, BM Beadle, SEB Ponce, V Takiar, IC Gibbs, ...
International Journal of Radiation Oncology* Biology* Physics 115 (1), 19-22, 2023
Mandat: US Department of Veterans Affairs
Tersedia di suatu tempat: 191
Nasopharyngeal carcinoma
YP Chen, ATC Chan, QT Le, P Blanchard, Y Sun, J Ma
The Lancet 394 (10192), 64-80, 2019
Mandat: National Medical Research Council, Singapore
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche
JT Erler, KL Bennewith, TR Cox, G Lang, D Bird, A Koong, QT Le, ...
Cancer cell 15 (1), 35-44, 2009
Mandat: US National Institutes of Health, Canadian Institutes of Health Research …
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ...
The Lancet 393 (10166), 40-50, 2019
Mandat: US National Institutes of Health, Damon Runyon Cancer Research Foundation
Prognostic Significance of p16INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
D Rischin, RJ Young, R Fisher, SB Fox, QT Le, LJ Peters, B Solomon, ...
Journal of clinical oncology 28 (27), 4142-4148, 2010
Mandat: US National Institutes of Health
Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines
V Grégoire, K Ang, W Budach, C Grau, M Hamoir, JA Langendijk, A Lee, ...
Radiotherapy and Oncology 110 (1), 172-181, 2014
Mandat: US National Institutes of Health
Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation
X Huang, L Ding, KL Bennewith, RT Tong, SM Welford, KK Ang, M Story, ...
Molecular cell 35 (6), 856-867, 2009
Mandat: US National Institutes of Health
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
EEW Cohen, RB Bell, CB Bifulco, B Burtness, ML Gillison, KJ Harrington, ...
Journal for immunotherapy of cancer 7, 1-31, 2019
Mandat: US National Institutes of Health, Cancer Research UK, National Institute for …
Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma
C Fakhry, Q Zhang, PF Nguyen-Tan, D Rosenthal, A El-Naggar, ...
Journal of clinical oncology 32 (30), 3365-3373, 2014
Mandat: US National Institutes of Health
Informasi terbitan dan pendanaan ditentukan secara otomatis oleh program komputer